QuidelOrtho Announces Q3 2024 Financial Results Release Date

QuidelOrtho Corporation (NASDAQ: QDEL), a leading global provider of in vitro diagnostic technologies, will release its financial results for the third quarter of 2024 on November 7, 2024, after market close. The quarter ended on September 29, 2024. Following the announcement, QuidelOrtho will conduct a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss these results. Participants can access the call via the "Events & Presentations" section of the "Investor Relations" page on the company's website. The presentation materials will also be available there at the time of the call. For those unable to join the webcast, the call can be accessed by phone using the provided domestic and international numbers with Conference ID 117739. A replay will be available on the company's website shortly after the call.

QuidelOrtho is renowned for its innovative diagnostics that enhance healthcare delivery worldwide. The company specializes in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, providing fast, accurate, and reliable diagnostics across various healthcare settings. QuidelOrtho's commitment to innovation and collaboration aims to advance diagnostic solutions globally.

For more information, visit quidelortho.com and follow QuidelOrtho on social media platforms.

About QuidelOrtho Corporation: QuidelOrtho Corporation is a prominent entity in the in vitro diagnostics sector, offering solutions that convert data into actionable insights. The company supports healthcare professionals in identifying trends, making informed decisions, and improving patient outcomes.